Moreover, EGFR amplification is often associated with Ink4a mutation and TP53 mutation in the EGFR signaling pathway in primary GBMs 36, and the overexpression of the dual mutations of EGFR Ink4a-Arf led to the development of glioma-like lesions 37. Here, CDKN2A is linked to central nervous system cancer.